|1.82||-0.02 / -1.09%|
As of 3:59pm ET
|1.82||-0.0004 / -0.02%|
The 5 analysts offering 12-month price forecasts for CTi Biopharma Corp have a median target of 4.50, with a high estimate of 8.00 and a low estimate of 3.50. The median estimate represents a +147.25% increase from the last price of 1.82.
The current consensus among 5 polled investment analysts is to Buy stock in CTi Biopharma Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.